PPARG and early-onset autosomal dominant Alzheimer disease: In addition, blocking NF-κB and sEH as well as enabling PPARα and PPARγ expression could alleviate neurodegenerative diseases such as Alzheimer’s disease (Certo et al., 2015, Prashantha et al., 2020).